Tower Research Capital LLC (TRC) - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 58 filers reported holding SECOND SIGHT MED PRODS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2019$15,000
+114.3%
19,206
+129.3%
0.00%
Q1 2019$7,000
-36.4%
8,377
+43.0%
0.00%
-100.0%
Q4 2017$11,000
-62.1%
5,857
-76.1%
0.00%
-50.0%
Q3 2017$29,000
+222.2%
24,533
+252.5%
0.00%
+100.0%
Q2 2017$9,000
-50.0%
6,960
-52.9%
0.00%
-50.0%
Q1 2017$18,0000.0%14,775
+65.5%
0.00%0.0%
Q4 2016$18,000
+1700.0%
8,928
+2541.4%
0.00%
Q2 2016$1,000
-66.7%
338
-34.4%
0.00%
Q4 2015$3,000
-91.4%
515
-91.2%
0.00%
-100.0%
Q3 2015$35,000
-68.2%
5,856
-27.0%
0.00%
-70.0%
Q2 2015$110,000
+746.2%
8,025
+704.1%
0.01%
+400.0%
Q1 2015$13,000
+8.3%
998
-12.1%
0.00%
+100.0%
Q4 2014$12,0001,1350.00%
Other shareholders

There were no reported owners of SECOND SIGHT MED PRODS INC in Q1 2017.

NameSharesValueWeighting ↓
View complete list of SECOND SIGHT MED PRODS INC shareholders